BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 38354169)

  • 1. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
    Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
    PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).
    Lintzeris N; Mills L; Abelev SV; Suraev A; Arnold JC; McGregor IS
    Harm Reduct J; 2022 Jul; 19(1):88. PubMed ID: 35907959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
    Hammond D; Goodman S
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
    Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R
    JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina.
    Fernández N; Cappello MG; Quiroga PN
    Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure.
    Lambros AM; Sagar KA; Dahlgren MK; Kosereisoglu D; El-Abboud C; Smith RT; Gruber SA
    Sci Rep; 2023 Apr; 13(1):5869. PubMed ID: 37041309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid Exposure and Subjective Effects of THC and CBD in Edible Cannabis Products.
    Gibson LP; Mueller RL; Winiger EA; Klawitter J; Sempio C; Williams S; Bryan AD; Bidwell LC; Hutchison KE
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):320-334. PubMed ID: 36378267
    [No Abstract]   [Full Text] [Related]  

  • 8. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
    Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
    JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).
    Lintzeris N; Mills L; Suraev A; Bravo M; Arkell T; Arnold JC; Benson MJ; McGregor IS
    Harm Reduct J; 2020 Jun; 17(1):37. PubMed ID: 32513180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure.
    Black T; Baccetto SL; Barnard IL; Finch E; McElroy DL; Austin-Scott FVL; Greba Q; Michel D; Zagzoog A; Howland JG; Laprairie RB
    Sci Rep; 2023 Nov; 13(1):21070. PubMed ID: 38030657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.
    Gurgenci T; Hardy J; Huggett G; Foster K; Pelecanos A; Greer R; Philip J; Haywood A; Mendis R; Yates P; Good P
    Trials; 2024 May; 25(1):293. PubMed ID: 38693590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
    Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.
    Fedorova EV; Wong CF; Ataiants J; Iverson E; Conn BM; Lankenau SE
    Drug Alcohol Depend; 2021 Apr; 221():108648. PubMed ID: 33676073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome.
    Abi-Jaoude E; Bhikram T; Parveen F; Levenbach J; Lafreniere-Roula M; Sandor P
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):835-845. PubMed ID: 36040329
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants.
    Bansal S; Zamarripa CA; Spindle TR; Weerts EM; Thummel KE; Vandrey R; Paine MF; Unadkat JD
    Clin Pharmacol Ther; 2023 Sep; 114(3):693-703. PubMed ID: 37313955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients.
    Ajrawat P; Yang Y; Wasilewski E; Leroux T; Ladha KS; Bhatia A; Singh M; Thaker S; Kapoor M; Furlan AD; Kotra LP; Clarke H
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):267-281. PubMed ID: 36342776
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys.
    Carey LM; Maguire DR; France CP
    Drug Alcohol Depend; 2023 Mar; 244():109787. PubMed ID: 36753805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.
    Hutten NRPW; Arkell TR; Vinckenbosch F; Schepers J; Kevin RC; Theunissen EL; Kuypers KPC; McGregor IS; Ramaekers JG
    Psychopharmacology (Berl); 2022 Nov; 239(11):3731-3741. PubMed ID: 36227352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
    Lee D; Karschner EL; Milman G; Barnes AJ; Goodwin RS; Huestis MA
    Drug Alcohol Depend; 2013 Jun; 130(1-3):68-76. PubMed ID: 23146820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Dispensing and Utilization Patterns of Medical Cannabis Products in State Licensed Cannabis Dispensaries.
    Tanco K; Olson A; Fellman B; Jankowski M; Lai SY; Shete S; Harbison K; Scheid J; Bruera E
    J Palliat Med; 2023 Nov; 26(11):1482-1487. PubMed ID: 37285183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.